The Food and Drug Administration has approved Atripla Tablets, a fixed-dose combination of three widely used antiretroviral drugs in a single tablet for the treatment of HIV-1 infection in adults. Atripla is to be taken once a day alone or in combination with other antiretroviral products.
美国食品药品监督管理局已批准Atripla片剂，这是一种将三种广泛使用的抗逆转录病毒药物制成的固定剂量复方单片制剂，用于治疗成人HIV-1感染。Atripla应每天服用一次，可单独服用或与其他抗逆转录病毒产品联合使用。
